RT @Wilcock_v2: On behalf of all of my co-authors, I am sharing a collective response to the book "Doctored" by Charles Piller and in respo…

RT @grinberg_t: Science evolves via testing and iteration. #Alzheimer’s research has improved diagnosis, risk understanding, & treatments t…

@ProfRobHoward Cassava is different imo, when there is commercial / investment money involved like for Methylene Blue things go on until the money stops

@ProfRobHoward One always needs to be alert to fraud, science’s response is rigour (like for clinical trials) and replication (at earlier stages). There are over 81000 hits for Amyloid Beta on Pubmed, one or a few bad apples doesn’t contaminate the field no matter how much some would like it to

Finally, Therapeutic Antibodies Start to Reduce Tangles (ALZFORUM). This is old news now but I’ve been looking at UCB’s Brepanemab again and find these data intriguing. Are we finally starting to see tau disease modification? Looking for more on this one.

RT @ProfRobHoward: Presumably, because it looks colourful and dramatic, Methylene Blue gets everywhere. Even, the laughable current efforts…

RT @roberchiesa: Check out this article just published in @NatureComms Prion protein promotes copper toxicity in Wilson disease. Great team…

RT @UCLTRO: 🎉Congratulations to Professor Paola Giunti on receiving the Partnership with Industry award! We are proud to help nurture re…

RT @UCL_QS_CNMD: Now open for registration: UK Neuromuscular Translational Research Conference - a scientific mee…

RT @jk_rowling: This 'why do you care about a tiny fraction of the population?' line is, and always was, utterly ridiculous. Gender ideol…

RT @jmschott: New *open access* paper in @alzdemjournals — with the @alzassociation #GBSC we compared 33 different plasma p-tau assays. TLD…

@foltynie A clear answer is the most important result, disappointing but research moves on

RT @Nature: The US Centers for Disease Control and Prevention (CDC) has mandated that all scientific manuscripts produced by its researcher…

RT @JNNP_BMJ: White matter abnormalities in healthy E200K carriers may serve as an early biomarker for genetic Creutzfeldt-Jakob disease (g…

International Alzheimer’s prevention trial in young adults begins – WashU Medicine using Remternetug from Eli Lily. Good luck!

RT @DrLKVaughan: Throwing my hat in the ring for @RCPhysicians Clinical Vice President. Great to see so many nominations for President, CV…

RT @jmschott: Latest paper led by @Sarah_naomi_1 in the @MRCLHA Insight 46 study — Physical activity across life may buffer the cognitive i…

RT @LittlePersonDoc: @Parody_RCGP @DrAsifQasim Same. @DrAsifQasim for President and @DrLKVaughan for VP. Change is needed and change is…

RT @Brain1878: Kovacs et al. report that autopsy-confirmed cases of amyloid-β predominant AD neuropathologic change (AP-ADNC) – marked by s…